{"entity":{"type":"insider","cik":"0001365429","url":"/insider/0001365429","json_url":"/insider/0001365429.json","name":"Three Arch Management IV, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":42,"n_filings":9,"first":"2011-02-18","last":"2015-12-16","span_basis":"filed_date"},"name_variants":[{"name":"Three Arch Management IV, L.L.C.","source":"filing","n_filings":9,"first_seen":"2011-02-18","last_seen":"2015-12-16"}],"transactions":[{"id":8544721,"accession":"0001209191-15-085648","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-15-085648","line_url":"/filing/0001209191-15-085648","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"JAEGER WILFRED E; THREE ARCH MANAGEMENT III LLC; Three Arch Management IV, L.L.C.","owner_display_name":"JAEGER WILFRED E","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10360.0,"shares_display":"10,360","price_per_share":19.5656,"price_display":"19.57","price_state":"stated","total_value":202699.616,"total_display":"202,699.62","total_whole":"202,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-16","filed_date":"2015-12-16","scope":"insider","n_lines":4},{"id":8544703,"accession":"0001209191-15-085648","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-15-085648","line_url":"/filing/0001209191-15-085648","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"JAEGER WILFRED E; THREE ARCH MANAGEMENT III LLC; Three Arch Management IV, L.L.C.","owner_display_name":"JAEGER WILFRED E","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54572.0,"shares_display":"54,572","price_per_share":20.1041,"price_display":"20.10","price_state":"stated","total_value":1097120.9452,"total_display":"1,097,120.95","total_whole":"1,097,121","shares_owned_after":5066.0,"shares_owned_after_display":"5,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-16","scope":"insider","n_lines":4},{"id":8544679,"accession":"0001209191-15-085648","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-085648","line_url":"/filing/0001209191-15-085648","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"JAEGER WILFRED E; THREE ARCH MANAGEMENT III LLC; Three Arch Management IV, L.L.C.","owner_display_name":"JAEGER WILFRED E","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3922.0,"shares_display":"3,922","price_per_share":20.0881,"price_display":"20.09","price_state":"stated","total_value":78785.5282,"total_display":"78,785.53","total_whole":"78,786","shares_owned_after":31763.0,"shares_owned_after_display":"31,763","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-16","scope":"insider","n_lines":4},{"id":8827793,"accession":"0001209191-15-070494","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-070494","line_url":"/filing/0001209191-15-070494","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"THREE ARCH MANAGEMENT III LLC; JAEGER WILFRED E; Three Arch Management IV, L.L.C.","owner_display_name":"THREE ARCH MANAGEMENT III LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":18.22,"price_display":"18.22","price_state":"stated","total_value":2186400.0,"total_display":"2,186,400.00","total_whole":"2,186,400","shares_owned_after":33682.0,"shares_owned_after_display":"33,682","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-10","filed_date":"2015-09-14","scope":"insider","n_lines":4},{"id":8886382,"accession":"0001209191-15-066727","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-15-066727","line_url":"/filing/0001209191-15-066727","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"JAEGER WILFRED E; Three Arch Management IV, L.L.C.; THREE ARCH MANAGEMENT III LLC","owner_display_name":"JAEGER WILFRED E","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":630000.0,"shares_display":"630,000","price_per_share":15.7,"price_display":"15.70","price_state":"stated","total_value":9891000.0,"total_display":"9,891,000.00","total_whole":"9,891,000","shares_owned_after":92386.0,"shares_owned_after_display":"92,386","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-18","scope":"insider","n_lines":4},{"id":8886376,"accession":"0001209191-15-066727","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-066727","line_url":"/filing/0001209191-15-066727","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"JAEGER WILFRED E; Three Arch Management IV, L.L.C.; THREE ARCH MANAGEMENT III LLC","owner_display_name":"JAEGER WILFRED E","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130000.0,"shares_display":"130,000","price_per_share":16.32,"price_display":"16.32","price_state":"stated","total_value":2121600.0,"total_display":"2,121,600.00","total_whole":"2,121,600","shares_owned_after":400581.0,"shares_owned_after_display":"400,581","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-18","scope":"insider","n_lines":4},{"id":8943709,"accession":"0001209191-15-066384","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-066384","line_url":"/filing/0001209191-15-066384","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"Three Arch Management IV, L.L.C.; THREE ARCH MANAGEMENT III LLC; JAEGER WILFRED E","owner_display_name":"Three Arch Management IV, L.L.C.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92215.0,"shares_display":"92,215","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":1544601.25,"total_display":"1,544,601.25","total_whole":"1,544,601","shares_owned_after":464177.0,"shares_owned_after_display":"464,177","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-13","filed_date":"2015-08-17","scope":"insider","n_lines":4},{"id":9269702,"accession":"0001209191-15-066162","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-066162","line_url":"/filing/0001209191-15-066162","is_derivative":false,"issuer_cik":"0001365429","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001365429","owner_cik":null,"owner_name":"JAEGER WILFRED E; THREE ARCH MANAGEMENT III LLC; Three Arch Management IV, L.L.C.","owner_display_name":"JAEGER WILFRED E","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97785.0,"shares_display":"97,785","price_per_share":17.4897,"price_display":"17.49","price_state":"stated","total_value":1710230.3145,"total_display":"1,710,230.31","total_whole":"1,710,230","shares_owned_after":509289.0,"shares_owned_after_display":"509,289","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2015-08-14","scope":"insider","n_lines":4},{"id":8375760,"accession":"0001209191-15-066143","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-066143","line_url":"/filing/0001209191-15-066143","is_derivative":false,"issuer_cik":"0001190474","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190474","owner_cik":null,"owner_name":"Three Arch Management IV, L.L.C.; THREE ARCH MANAGEMENT III LLC; JAEGER WILFRED E","owner_display_name":"Three Arch Management IV, L.L.C.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97785.0,"shares_display":"97,785","price_per_share":14.4897,"price_display":"14.49","price_state":"stated","total_value":1416875.3145,"total_display":"1,416,875.31","total_whole":"1,416,875","shares_owned_after":509289.0,"shares_owned_after_display":"509,289","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2015-08-14","scope":"insider","n_lines":4},{"id":7087002,"accession":"0001181431-14-036963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-036963","line_url":"/filing/0001181431-14-036963","is_derivative":false,"issuer_cik":"0001190472","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190472","owner_cik":null,"owner_name":"THREE ARCH ASSOCIATES IV LP; Three Arch Management IV, L.L.C.; JAEGER WILFRED E; THREE ARCH PARTNERS IV LP; WAN MARK A","owner_display_name":"THREE ARCH ASSOCIATES IV LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":12.29,"price_display":"12.29","price_state":"stated","total_value":3072500.0,"total_display":"3,072,500.00","total_whole":"3,072,500","shares_owned_after":557126.0,"shares_owned_after_display":"557,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider","n_lines":2},{"id":6788558,"accession":"0001209191-14-012994","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-012994","line_url":"/filing/0001209191-14-012994","is_derivative":false,"issuer_cik":"0001190472","issuer_name":"CONCERT PHARMACEUTICALS, INC.","issuer_ticker":"CNCE","issuer_name_source":null,"issuer_url":"/issuer/0001190472","owner_cik":null,"owner_name":"THREE ARCH PARTNERS IV LP; WAN MARK A; JAEGER WILFRED E; Three Arch Management IV, L.L.C.; THREE ARCH ASSOCIATES IV LP","owner_display_name":"THREE ARCH PARTNERS IV LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":103500.0,"shares_display":"103,500","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1449000.0,"total_display":"1,449,000.00","total_whole":"1,449,000","shares_owned_after":801726.0,"shares_owned_after_display":"801,726","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-19","filed_date":"2014-02-21","scope":"insider","n_lines":2},{"id":9014598,"accession":"0001181431-11-011594","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001181431-11-011594","line_url":"/filing/0001181431-11-011594","is_derivative":false,"issuer_cik":"0001190472","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001190472","owner_cik":null,"owner_name":"JAEGER WILFRED E; WAN MARK A; Three Arch Management IV, L.L.C.; THREE ARCH PARTNERS IV LP; THREE ARCH ASSOCIATES IV LP","owner_display_name":"JAEGER WILFRED E","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1289790.0,"shares_display":"1,289,790","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":6448950.0,"total_display":"6,448,950.00","total_whole":"6,448,950","shares_owned_after":3749918.0,"shares_owned_after_display":"3,749,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-16","filed_date":"2011-02-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367920","name":"CONCERT PHARMACEUTICALS, INC.","url":"/issuer/0001367920","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2014-02-21","last_seen":"2015-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001427925","name":"ACELRX PHARMACEUTICALS INC","url":"/issuer/0001427925","role":"Ten percent owner","n_filings":1,"first_seen":"2011-02-18","last_seen":"2011-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001365429","retrieved_at":"2026-08-24T17:04:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}